Page 119778 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ INDEX ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼EMEA Recommendz a N fuesitiouri 08/7/3(木) 20:39 ─────────────────────────────────────── ■題名 : EMEA Recommendz a N ■名前 : fuesitiouri <jateexesced@atlaskit.com> ■日付 : 08/7/3(木) 20:39 ■Web : http://google.com/iqnhoa -------------------------------------------------------------------------
LONDON, June 6, 2008-The European Medicines power (MEEA) has recommended updating the result intelligence for epoetin-containing medicines with a new caution fro their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients torture cancer. Epoetin-containing medicines are indicated in pagients wikth persistent acheter cialis generique incompetent and for the treatment of anaemia in symptomatic patients with non-myeloid growths receivin chemotherapy. The power痴 council for sanative Products for Good Samaritan Use (CHMP) had rehashinged new details from stduies that showed a increased endanger f growth achetter cialis ascension, venous thromboembolism and shorter all-inclusive sruvival in cancer patients who admitd epoetins compared to patients who did not clear them. Following this notice, the CHMP concluded, at its June 2008 conference, that the gains of epoetins persist acheter cialis surpass their endangers in the approved indications. on the other hand, in cancer patients with a reasonably great flair-expectancy, the improve of using epoetins does not surpass the hazard acheter levitra generique sarcoma ascension and shorter inclusive survival and consequently the council concluded that in these patients anaemia should be corrected with blood transfusions. |